Research Renaissance: Exploring the Future of Brain Science

Karen Toffler Charitable Trust
  • 5.0 (3)
  • LIFE SCIENCES

Welcome to Research Renaissance, presented by the Karen Toffler Charitable Trust. We invite you into the stories, struggles, and breakthroughs shaping the future of human health. From cutting-edge brain science to discoveries transforming how we heal, adapt, and thrive, we explore the ideas that matter and the people behind them. Each episode features early-career researchers driven by curiosity, entrepreneurs turning bold ideas into lifesaving innovations, and leaders in investment, policy, and research who help move discoveries into the real world. Together, we look across diseases, technologies, and research fields to understand not just what is changing, but why it matters—for patients, families, and the future we all share. Join us as we uncover new insights, spark collaboration, and illuminate the science that can improve lives.

  1. 2D AGO

    Bioethics at the Bedside and Beyond: How Ethics Shaped Modern Medicine

    Modern medicine is not shaped by science alone. It is shaped by ethics, trust, and the difficult decisions made when technology moves faster than society can understand it. In this episode of Research Renaissance, legendary bioethicist Dr. Art Caplan reflects on a career that helped build the field of bioethics from the ground up. From surviving polio as a child to shaping national policies on organ transplantation, informed consent, and end-of-life care, Caplan offers a deeply personal and historically grounded perspective on how ethical thinking became essential to modern healthcare. The conversation explores the lingering distrust born from COVID-19, the ethical blind spots of artificial intelligence, the environmental cost of data infrastructure, and why communication between science and the public may be the most urgent challenge ahead. This episode is both a history lesson and a call to action. Ethics is not abstract philosophy. It is practical problem-solving for real people, real patients, and real consequences. Key Takeaways Bioethics emerged to solve real clinical dilemmas, not theoretical debates.Policies such as informed consent, brain-death standards, and organ allocation were shaped by early bioethics work.Public trust in medicine declined significantly after COVID-19 due to shifting scientific guidance and poor communication.AI introduces ethical risks beyond autonomy and bias, including environmental strain, privacy vulnerability, and unclear liability.The U.S. healthcare system’s structure, not just its technology, drives many ethical failures.Ethics must move from academic journals into communities through direct engagement and public dialogue.   Guest Spotlight Art Caplan, PhD One of the founders of modern bioethics, Dr. Caplan has advised governments, medical institutions, and research bodies on issues ranging from organ transplantation policy to emerging AI ethics. His work bridges philosophy, clinical medicine, and public engagement. Topics Discussed Origins of bioethics as a disciplineHuman subject protections and informed consentEnd-of-life decision frameworks and hospice careVaccine hesitancy and post-pandemic mistrustEthical governance of artificial intelligence in healthcareEnvironmental implications of digital infrastructureStructural inequities in U.S. healthcare deliveryThe role of communication in rebuilding scientific trustIf you found this conversation valuable: Follow Research Renaissance for more conversations at the intersection of science, policy, and human health.Share this episode with colleagues working in healthcare, research, or ethics.Leave a review to help more listeners engage with these critical discussions.To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

    59 min

  2. APR 15

    Can We Halt Parkinson’s Progression? Targeted Brain Therapies Explained

    Parkinson’s disease begins decades before symptoms appear — and by the time tremors start, brain changes have already been unfolding for years. In this episode of Research Renaissance, host Deborah Westphal speaks with Dr.  Zachary Sorrentino, neurosurgeon, physician-scientist, and 2025 Toffler Scholar at the University of Florida. Dr. Sorrentino explains how misfolded proteins like alpha-synuclein spread through the brain, how deep brain stimulation helps restore movement, and why preventing dementia in Parkinson’s patients may be the next major frontier. Drawing from both the operating room and the research lab, Dr. Sorrentino shares how his team analyzes proteins directly from surgical tools used in living patients — offering unprecedented insight into disease progression. This is a powerful conversation about aging, brain vulnerability, precision therapies, and the human side of neurosurgery. 🔑 Key Takeaways Why age is the strongest risk factor for Parkinson’s disease How misfolded alpha-synuclein spreads through the brain What deep brain stimulation actually does Why Parkinson’s symptoms begin decades before diagnosis The connection between Parkinson’s and dementia How targeted drug delivery through brain blood vessels may shape the future The emotional realities of neurosurgery and patient care ⏱️ Episode Timestamps 00:00 – Introduction to Parkinson’s and Lewy body disorders 02:30 – The MD-PhD pathway and physician-scientist model 08:30 – What deep brain stimulation does 10:00 – The 20-year silent phase of Parkinson’s 12:00 – Studying proteins from surgical tools 16:00 – Why dementia is the greatest fear 24:00 – How misfolded proteins spread 27:00 – The role of aging in neurodegeneration 31:00 – Detecting pathological proteins in living patients 42:00 – Stroke breakthroughs in the last decade 48:00 – Targeted therapies and personalized brain medicine 54:00 – The human side of neurosurgery 👤 Guest Dr. Zachary Sorrentino Neurosurgeon and Physician-Scientist University of Florida 2025 Toffler Scholar 🧠 Topics Covered Parkinson’s diseaseAlpha-synuclein and Lewy bodiesProtein misfolding and neurodegenerationDeep brain stimulation (DBS)Targeted gene therapy deliveryStroke intervention advancesAging and brain health 💬 Join the Conversation If this episode deepened your understanding of Parkinson’s disease: Follow Research Renaissance Share this episode with someone in neuroscience or medicine Leave a review on Apple Podcasts or Spotify Subscribe for more conversations shaping the future of human health To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

    59 min

  3. APR 8

    Is Parkinson’s a Whole-Body Disease? Rethinking the Immune System’s Role

    For decades, Parkinson’s disease has been viewed primarily as a disorder of dopamine-producing brain cells. But what if that’s only part of the story? In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Rebecca Wallings, Assistant Professor of Neurology at Indiana University’s Stark Neuroscience Research Institute, to explore a groundbreaking shift in how we understand Parkinson’s. Dr. Wallings explains why the immune system — and specifically immune cell exhaustion — may be a key driver of disease progression. She challenges the prevailing “too much inflammation” narrative and introduces the provocative idea that Parkinson’s may involve a burned-out, aging immune system rather than simply an overactive one. This conversation dives into: The role of lysosomes in immune and brain cells Why most preclinical Parkinson’s models may overlook aging Gut-first vs. brain-first Parkinson’s subtypes Immune exhaustion and its connection to aging Lifestyle factors that may influence disease progression Why future therapies may need to be personalized Key Takeaways Parkinson’s may be a whole-body condition, not just a brain disease. Aging dramatically alters immune function — yet many models study “young” immune systems. Immune exhaustion may prevent proper resolution of inflammation. Non-motor symptoms (constipation, sleep disorders, loss of smell) can appear decades before diagnosis. Stratifying patients by biological immune age could transform treatment strategies.  About Our Guest Dr. Rebecca Wallings Assistant Professor of Neurology Indiana University – Stark Neuroscience Research Institute Dr. Wallings studies the role of immune cell exhaustion and aging in Parkinson’s disease, challenging traditional pathology-focused models and exploring translational therapeutic strategies. Resources Mentioned Stark Neuroscience Research InstituteResearch on immune checkpoint inhibitorsStudies on REM Behavior Disorder and Parkinson’s riskResearch into biological aging clocks Enjoyed This Episode? If this conversation expanded your thinking: Subscribe to Research RenaissanceLeave a review on Apple Podcasts or SpotifyShare this episode with a colleague or friendFollow us for more conversations at the frontier of health scienceTo learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

    54 min

  4. APR 1

    How MicroRNAs Could Change Early Detection of Alzheimer’s Disease

    In this episode of Research Renaissance, host Deborah Westphal sits down with neuroscientist Micaelly Alves, PhD candidate at Temple University and a 2025 Toffler Scholar supported by the Karen Toffler Charitable Trust. Micaelly shares her personal journey into neuroscience, inspired by watching her grandmother’s battle with Alzheimer’s disease, and dives into groundbreaking research on microRNAs, tiny molecules that may hold the key to earlier diagnosis and more personalized treatment for Alzheimer’s and cerebral amyloid angiopathy. The conversation explores how brain research is evolving, why personalized medicine matters, and how emerging technologies like RNA sequencing and bioinformatics are accelerating discovery. ⭐ Key Takeaways • How microRNAs regulate brain pathways linked to Alzheimer’s disease • Why Alzheimer’s may begin developing 20 years before symptoms appear • The role of blood-brain barrier health in cognitive decline • How extracellular vesicles may enable early blood-based diagnostics • Why personalized medicine is the future of neurological care • The challenges and promise of big data and AI in neuroscience • How philanthropy supports early-career researchers and innovation 🔬 Resources & Mentions • Temple University Neuroscience Program • MicroRNA research in Alzheimer’s disease • Cerebral amyloid angiopathy (CAA) • RNA sequencing and transcriptomics 👉 Enjoying Research Renaissance? If you found this episode helpful: ✅ Subscribe on Apple Podcasts or Spotify ✅ Share this episode with a friend or colleague ✅ Leave a review to help more listeners discover the show To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

    51 min

  5. MAR 25

    From Neuroscience to State Policy: How Science Shapes Decisions in California

    How does neuroscience shape state policy? And what happens when scientists step inside government? In this episode of Research Renaissance, Deborah Westphal sits down with Dr. Julianne McCall, CEO of the California Council on Science and Technology (CCST), to explore how scientific thinking informs public policy in one of the world’s largest economies. From spinal cord injury research in Germany to advising California’s Governor during COVID-19, Dr. McCall shares how scientists can help governments navigate AI, climate, energy, and public health in a rapidly accelerating world. This conversation reveals what it really takes to translate research into action. Key Takeaways Why scientific training is uniquely suited for policymaking How California integrates nonpartisan science advisors into government The role of “the Third House” in shaping legislation Why AI policy must evolve every six months How fellowship programs are training the next generation of science policy leaders Why community and trust are central to effective governance About the Guest Dr. Julianne McCall CEO, California Council on Science and Technology Neuroscientist turned science policy leader with experience spanning academia, international research, state government, and public engagement. Resources & Links California Council on Science and Technology: https://ccst.us CCST Science & Technology Policy Fellowship Calls for Experts (AI, Quantum, Emerging Technologies) Science & Technology Week at the California State Capitol Listen & Connect If you found this episode valuable: Follow Research Renaissance Share this episode with a colleague in science or public policy Leave a review on Apple Podcasts or Spotify Science doesn’t move society alone. It needs translation. To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

    57 min

  6. MAR 18

    The Vagus Nerve Revolution: How Bioelectronic Medicine Is Changing the Future of Healthcare

    In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Şiyar Bahadır, neurosurgeon and Elmezzi Scholar at the Feinstein Institute for Medical Research, to explore the cutting edge of neuroscience, bioelectronic medicine, and the powerful role of the vagus nerve in regulating nearly every organ system in the body. Dr. Bahadır shares his journey from the operating room to advanced research, explains how mapping the brain and nervous system is revolutionizing patient outcomes, and dives into groundbreaking therapies using electrical stimulation to treat inflammatory diseases like rheumatoid arthritis. The conversation also uncovers how the brain reorganizes itself after trauma, the future of precision neurosurgery, and why the vagus nerve may hold the key to an entirely new form of medicine. Key Takeaways The vagus nerve acts as a central communication highway between the brain and major organsHow bioelectronic medicine uses electrical stimulation instead of drugs to treat diseaseReal-world success of vagus nerve stimulation for rheumatoid arthritis (now FDA approved)Why mapping neural networks improves surgical precision and recoveryThe brain’s ability to reorganize itself (plasticity) after injury or surgeryHow AI and advanced imaging are shaping the future of neurosurgery Guest Information Dr. Şiyar Bahadır Neurosurgeon | Elmezzi Scholar | Feinstein Institute for Medical Research 📧 Email: sbahadir@northwell.edu 🔗 LinkedIn: Şiyar Bahadır Resources Mentioned The Great Nerve by Dr. Kevin Tracy (on the vagus nerve and bioelectronic medicine)If you enjoyed this episode, please: ✅ Subscribe to Research Renaissance ✅ Leave a review on Apple Podcasts or Spotify ✅ Share this episode with colleagues interested in neuroscience and medical innovation Your support helps us bring more groundbreaking research conversations to you! To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

    1h 4m

  7. MAR 11

    Inside Health Informatics: Data, Decisions, and the Future of Patient Care

    Healthcare today runs on data, but few people understand how deeply information systems shape patient outcomes, clinician workflows, and long-term public health. In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Caterina (Cat) Lasome, a nationally recognized leader in health informatics and digital health transformation. Drawing from 23 years as an Army nurse and decades working across the Department of Defense, VA, NIH, and federal health systems, Cat explains how informatics sits at the intersection of clinical care, technology, and human behavior. Together, they explore what happens when data flows well, where systems still fracture, and why learning healthcare systems may be the key to safer, more adaptive medicine. Key Topics & Takeaways What health informatics actually is and why it affects every patient encounterHow military healthcare prepares clinicians for complexity at scaleWhy continuity of care between DoD and VA systems matters for veteransThe hidden role of data standards, interoperability, and governanceClinical practice guidelines and how they improve consistency without replacing judgmentBurnout, documentation burden, and the promise of ambient clinical listeningWhy healthcare struggles to learn from errors, and what aviation gets rightWhat a true “learning healthcare system” would require to function About the Guest Dr. Caterina (Cat) Lasome is a nationally recognized expert in health informatics, clinical systems, and digital health transformation. A retired Army nurse with 23 years of service, she has worked across the Department of Defense, Veterans Affairs, NIH, and HHS, and is the President & CEO at iON Informatics, LLC. To contact Dr. Lasome cat@ioninformatics.com.  Resources Mentioned Department of Defense Health SystemVeterans Health Administration (VA)Agency for Healthcare Research and Quality (AHRQ)Joint Trauma Registry (JTR)Electronic Health Records (EHRs)Ambient clinical documentation technology If you found this episode valuable: Subscribe to Research Renaissance on your favorite podcast platformShare this episode with colleagues working in healthcare, research, or policyLeave a review to help more listeners discover the showTo learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

    1h 20m

  8. MAR 4

    Why Alzheimer’s Is No Longer a Black Box: Science, Resilience, and the Path Forward

    For decades, Alzheimer’s disease was treated as an unavoidable consequence of aging. In this episode of Research Renaissance, Dr. Jessica Rexach explains why that framing is no longer true. Drawing on 20 years at the intersection of clinical neurology, genetics, and experimental neuroscience, Dr. Rexach walks us through a profound shift in the field. Today, scientists can model human brain circuits, measure Alzheimer’s pathology through blood-based biomarkers, and study why some brains remain cognitively resilient even with disease pathology present. The science, she argues, is ready. The real question is whether society will commit the resources needed to finish the job. Key Takeaways Alzheimer’s research has moved from broad hypotheses to precise, testable mechanismsBlood-based biomarkers have transformed clinical trials and early detectionBrain resilience, not just pathology, may hold the key to preventionCOVID-era investments unintentionally accelerated dementia research toolsThe biggest risk now is not scientific failure, but loss of funding and momentumGuest Information Dr. Jessica Rexach Assistant Professor, UCLA 2024 Toffler Scholar 📧 Email: jrexach@mednet.ucla.edu Listen & Subscribe If you found this episode valuable: Subscribe to Research Renaissance on Apple Podcasts or SpotifyShare this episode with colleagues, caregivers, or anyone interested in brain scienceLeave a review to help others discover the showTo learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

    59 min
See All (68)

Ratings & Reviews

5
out of 5
3 Ratings

About

Welcome to Research Renaissance, presented by the Karen Toffler Charitable Trust. We invite you into the stories, struggles, and breakthroughs shaping the future of human health. From cutting-edge brain science to discoveries transforming how we heal, adapt, and thrive, we explore the ideas that matter and the people behind them. Each episode features early-career researchers driven by curiosity, entrepreneurs turning bold ideas into lifesaving innovations, and leaders in investment, policy, and research who help move discoveries into the real world. Together, we look across diseases, technologies, and research fields to understand not just what is changing, but why it matters—for patients, families, and the future we all share. Join us as we uncover new insights, spark collaboration, and illuminate the science that can improve lives.

Information